Skadden, Arps, Slate, Meagher & Flom and Eubelius advised Fortress Investment Group in the transaction. Goodwin Procter and Harvest advised Celyad Oncology.Fortress Investment Group (“Fortress”) announced with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
